Search Results - "Eilertsen, Anette L"

Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system by Eilertsen, Anette L, Liestøl, Sigurd, Mowinckel, Marie-Christine, Hemker, H C, Sandset, Per-Morten

“…Recent studies have shown that hormone therapy (HT) is associated with an acquired resistance to activated protein C (APC). The aims of the present study were…”
Get more information

Relationship between sex hormone binding globulin and blood coagulation in women on postmenopausal hormone treatment by Eilertsen, Anette L, Dahm, Anders E.A, Høibraaten, Else, Lofthus, Cathrine M, Mowinckel, Marie-Christine, Sandset, Per M

“…Postmenopausal hormone therapy increases the risk of venous thrombosis. Sex hormone binding globulin (SHBG) is a suggested marker of ‘total estrogenicity’. The…”
Get full text

A microarray study on the effect of four hormone therapy regimens on gene transcription in whole blood from healthy postmenopausal women by Dahm, Anders E.A, Eilertsen, Anette L, Goeman, Jelle, Olstad, Ole Kristoffer, Øvstebø, Reidun, Kierulf, Peter, Mowinckel, Marie-Christine, Skretting, Grethe, Sandset, Per Morten

“…Abstract Background Postmenopausal hormone therapy is associated with many diseases and conditions, e.g., cardiovascular diseases and asthma, but the…”
Get full text

Tissue factor pathway inhibitor polymorphisms in women with and without a history of venous thrombosis and the effects of postmenopausal hormone therapy by Opstad, Trine B, Eilertsen, Anette L, Høibraaten, Else, Skretting, Grethe, Sandset, Per Morten

“…Postmenopausal hormone therapy is associated with marked reduction in tissue factor pathway inhibitor (TFPI) levels, and low TFPI levels have been associated…”
Get full text

Hormone therapy and raloxifene reduce the coagulation inhibitor potential by Andresen, Marianne S, Eilertsen, Anette L, Abildgaard, Ulrich, Sandset, Per Morten

“…The coagulation inhibitor potential (CIP) assay may detect major thrombophilia at a sensitivity of 100% and a specificity of 70–80%. Subnormal CIP might be…”
Get full text

Decreased lung cancer survival with hormone-replacement therapy: caused by a decreased tissue factor pathway inhibitor level? by Negaard, Helene F S, Eilertsen, Anette L, Dahm, Anders, Iversen, Per O, Østenstad, Bjørn, Sandset, Per M

Get full text